共 78 条
- [1] Anderson D(1995)Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks Mutat Res 330 115-181
- [2] Bishop JB(1986)31P nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites J Med Chem 29 1206-1210
- [3] Garner RC(1999)Antimutagenic effects of stobadine: review of results Life Sci 65 2015-2017
- [4] Ostrosky-Wegman P(1999)An overview of cyclophosphamide development and clinical applications Curr Pharm Des 5 555-560
- [5] Selby PB(1994)Metabolic differences between whole blood and isolated lymphocyte cultures for micronucleus (MN) induction by cyclophosphamide and benzo[a]pyrene Mutagenesis 9 307-313
- [6] Boyd VL(1991)Cyclophosphamide toxicity. Characterising and avoiding the problem Drugs 42 781-795
- [7] Robbins JD(1991)Drug metabolism in carcinogenesis and cancer chemotherapy Pharmacol Ther 51 275-289
- [8] Egan W(1997)Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization Biofactors 6 321-338
- [9] Ludeman SM(1976)The problem of oncostatic specificity of cyclophosphamide (NSC-26271): studies on reactions that control the alkylating and cytotoxic activity Cancer Treat Rep 60 309-315
- [10] Chorvatovicova D(1988)Chromosomal abnormalities and sister-chromatid exchange in bone marrow cells of mice and Chinese hamsters after inhalation and intraperitoneal administration. II. Cyclophosphamide Mutat Res 203 1-10